Featured companies in Company

Causaly
Causaly causaly.com
89

Featured

Biomedical research discovery tool.

  • Latest Funding

    $60 Million · Series B

  • Employees

    51 to 100

  • Investors

    Index Ventures, Index Ventures, Index Ventures, ICONIQ Growth, Pentech Ventures, Pentech Ventures, Marathon VC, Marathon VC

  • Business Model

    B2B, SAAS

  • Industries

    Health Tech, AI, Biotech, Pharma

  • Locations

    London

  • Contact

    •••••@causaly.com
    Unlock contact info

Beacon Therapeutics
Beacon Therapeutics beacontx.com
89

Featured

Oophthalmic gene therapy company to treat blinding retinal illnesses.

  • Latest Funding

    $120 Million · Series A

  • Employees

    1 to 10

  • Investors

    Syncona Partners LLP, Syncona Partners LLP

  • Industries

    Health Tech, Biotech

  • Locations

    London

  • Contact

    •••••@beacontx.com
    Unlock contact info

Mytos
Mytos mytos.bio
84

Featured

Mytos is building a fully-automated cell manufacture platform for Pharma

  • Latest Funding

    $19 Million · Series A

  • Employees

    11 to 50

  • Investors

    Buckley Ventures, Wing Venture Capital, IQ Capital Partners

  • Business Model

    B2B

  • Industries

    Hardware, Biotech, Pharma, Manufacturing

  • Locations

    London

  • Contact

    •••••@mytos.bio
    Unlock contact info

Full list of Biotech startups in UK

Complement Therapeutics
Complement Therapeutics complementtx.com
84

Preclinical stage treatment for geographic atrophy.

  • Latest Funding

    $79 Million · Series A

  • Industries

    Biotech

  • Locations

    London

  • Employees

    1 to 10

  • Investors

    Forbion Capital Partners, Gimv

  • Contact

    •••••@complementtx.com
    Unlock contact info

Apollo Therapeutics
Apollo Therapeutics apollotherapeutics.com
79

Portfolio of pharmaceutical research and discovery.

  • Latest Funding

    $230 Million · Series C

  • Industries

    Biotech, Pharma

  • Locations

    London

  • Employees

    1 to 10

  • Investors

    Patient Square Capital, Rock Springs Capital

  • Contact

    •••••@apollotherapeutics.com
    Unlock contact info

Lindus Health
Lindus Health lindushealth.com
75

Clinical trials platform.

  • Latest Funding

    $18 Million · Series A

  • Industries

    Health Tech, Biotech

  • Locations

    London

  • Employees

    11 to 50

  • Business Model

    B2B, SAAS

  • Investors

    Valar Ventures, Creandum, Seedcamp, Atomico, Firstminute Capital, Hambro Perks Ltd., Calm/Storm Ventures

  • Contact

    •••••@lindushealth.com
    Unlock contact info

Ori Biotech
Ori Biotech oribiotech.com
75

Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments.

  • Latest Funding

    $100 Million · Series B

  • Industries

    Health Tech, Biotech, Manufacturing

  • Locations

    London

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Kindred Capital, Octopus Ventures, Amadeus Capital

  • Contact

    •••••@oribiotech.com
    Unlock contact info

Quell Therapeutics
Quell Therapeutics quell-tx.com
75

Quell Therapeutics is a cell therapy company

  • Latest Funding

    $160 Million · Series B

  • Industries

    Health Tech, Edtech, Biotech, Manufacturing

  • Locations

    London

  • Employees

    101 to 250

  • Business Model

    B2B

  • Investors

    AlbionVC, Point72 Ventures

  • Contact

    •••••@quell-tx.com
    Unlock contact info

Tropic Biosciences
Tropic Biosciences tropicbioscience.com
75

Tropic Biosciences is a pioneering leader in the development of novel high-performing commercial tropical crop varieties and traits.

  • Latest Funding

    $35 Million · Series C

  • Industries

    Agritech, Biotech, Deep Tech, Manufacturing

  • Locations

    London

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Future Planet Capital

  • Contact

    •••••@tropicbioscience.com
    Unlock contact info

Laverock Therapeutics
Laverock Therapeutics laverocktx.com
75

Gene silencing platform for the creation of programmable, allogeneic cell therapies.

  • Latest Funding

    $16 Million · Seed

  • Industries

    Health Tech, Biotech

  • Locations

    London

  • Employees

    1 to 10

  • Investors

    Mercia Asset Management, UK Innovation & Science Seed Fund, Calculus Capital, NPIF Maven Equity Finance

  • Contact

    •••••@laverocktx.com
    Unlock contact info

AstronauTx
AstronauTx astronautx.bio
71

Clinical-stage research for alzheimer’s disease.

  • Latest Funding

    $59 Million · Series A

  • Industries

    Health Tech, Biotech

  • Locations

    Reading

  • Employees

    1 to 10

  • Investors

    EQT Partners, UCL Technology Fund, Brandon Capital, MPM Capital, Novartis Venture Fund

  • Contact

    •••••@astronautx.bio
    Unlock contact info

Achilles Therapeutics
Achilles Therapeutics achillestx.com
68

Immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer.

  • Latest Funding

    $68 Million · Series C

  • Industries

    Health Tech, Biotech

  • Locations

    London

  • Employees

    101 to 250

  • Business Model

    B2B

  • Investors

    Sixth Element Capital, Boxer Capital, Syncona Partners LLP, AlbionVC, Forbion Capital Partners, Invus

  • Contact

    •••••@achillestx.com
    Unlock contact info

Charm Therapeutics
Charm Therapeutics charmtx.com
68

CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.

  • Latest Funding

    $50 Million · Series A

  • Industries

    Health Tech, AI, Biotech, Data and Analytics

  • Locations

    London

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    General Catalyst, Khosla Ventures

  • Contact

    •••••@charmtx.com
    Unlock contact info

LabGenius
LabGenius labgeni.us
68

LabGenius is a biopharmaceutical company developing protein therapeutics using a machine learning-driven evolution engine.

  • Latest Funding

    $25 Million

  • Industries

    Health Tech, AI, Biotech, Deep Tech, Machine Learning, Robotics, Manufacturing

  • Locations

    London

  • Employees

    51 to 100

  • Business Model

    B2B

  • Investors

    Kindred Capital, Atomico

  • Contact

    •••••@labgeni.us
    Unlock contact info

ReViral
ReViral reviral.co.uk
68

ReViral is a biotechnology company that develops and offers antiviral therapies for patients.

  • Latest Funding

    $44 Million · Series C

  • Industries

    Health Tech, Biotech, Pharma

  • Locations

    London

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Novo A/S, Andera Partners

  • Contact

    •••••@reviral.co.uk
    Unlock contact info

Umedeor
Umedeor umed.io
68

Platform to automate the clinical studies process.

  • Latest Funding

    $12 Million · Series A

  • Industries

    Health Tech, Biotech

  • Locations

    London

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Playfair, AlbionVC, 11.2 Capital, Delin Ventures

  • Contact

    •••••@umed.io
    Unlock contact info

Flarin
Flarin flarin.co.uk
68

Patent-protected anti-inflammatory painkiller.

  • Latest Funding

    $6.3 Million · Series A

  • Industries

    Biotech, Pharma

  • Locations

    London

  • Employees

    1 to 10

  • Business Model

    B2C

  • Investors

    ITV AdVentures

  • Contact

    •••••@flarin.co.uk
    Unlock contact info

Genomes
Genomes genomes.io
68

User-owned genomics database platform.

  • Latest Funding

    $20 Million · Series A

  • Industries

    Health Tech, Biotech

  • Locations

    London

  • Employees

    1 to 10

  • Business Model

    B2C

  • Investors

    GEM Digital

  • Contact

    •••••@genomes.io
    Unlock contact info

Sitryx Therapeutics
Sitryx Therapeutics sitryx.com
67

Developer of therapeutics for chronic autoimmune and inflammatory diseases.

  • Latest Funding

    $39 Million · Series A

  • Industries

    Health Tech, Biotech

  • Locations

    Oxford

  • Employees

    11 to 50

  • Investors

    GSK, Sofinnova Partners, SV Health Investors, Oxford Science Enterprises

  • Contact

    •••••@sitryx.com
    Unlock contact info

ViaNautis
ViaNautis vianautis.com
67

Drug delivery platform.

  • Latest Funding

    $24 Million · Series A

  • Industries

    Health Tech, Biotech

  • Locations

    Cambridge

  • Employees

    1 to 10

  • Investors

    4BIO Capital, UCB Ventures, Business Growth Fund

  • Contact

    •••••@vianautis.com
    Unlock contact info

Epsilogen
Epsilogen epsilogen.com
64

Immuno-oncology company treats cancer with antibodies.

  • Latest Funding

    $42 Million

  • Industries

    Health Tech, Biotech, Deep Tech, Pharma, Manufacturing, Genetics

  • Locations

    London

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    AlbionVC, Epidarex Capital, Novartis Venture Fund

  • Contact

    •••••@epsilogen.com
    Unlock contact info

Kuano
Kuano kuano.ai
64

Quantum simulation platform for drug discovery.

  • Latest Funding

    $2.2 Million · Seed

  • Industries

    Health Tech, Biotech

  • Locations

    London

  • Employees

    1 to 10

  • Business Model

    B2B, SAAS

  • Investors

    Ascension Ventures, ACF Investors

  • Contact

    •••••@kuano.ai
    Unlock contact info

Pear Bio
Pear Bio pearbio.com
64

Cancer treatment predictor software.

  • Latest Funding

    $14 Million · Series A

  • Industries

    Health Tech, Biotech, Pharma

  • Locations

    London

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Hoxton Ventures, Octopus Ventures, Fly Ventures

  • Contact

    •••••@pearbio.com
    Unlock contact info

Hypervision Surgical
Hypervision Surgical hypervisionsurgical.com
64

Precision software for eye surgery.

  • Latest Funding

    $8.1 Million · Seed

  • Industries

    Health Tech, Biotech

  • Locations

    London

  • Employees

    1 to 10

  • Investors

    Redalpine

  • Contact

    •••••@hypervisionsurgical.com
    Unlock contact info

Basecamp Research
Basecamp Research basecamp-research.com
64

Protein discovery research and manufacturing.

  • Latest Funding

    $20 Million · Series A

  • Industries

    Biotech, Deep Tech

  • Locations

    London

  • Employees

    11 to 50

  • Investors

    SYSTEMIQ

  • Contact

    •••••@basecamp-research.com
    Unlock contact info

Multiomic Health
Multiomic Health multiomic.uk
64

Precision therapeutics discovery platform.

  • Latest Funding

    $6.2 Million · Seed

  • Industries

    Biotech

  • Locations

    London

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Hoxton Ventures

  • Contact

    •••••@multiomic.uk
    Unlock contact info

ImmuONE
ImmuONE immuone.com
64

3D human lung model developer.

  • Latest Funding

    $2.4 Million · Seed

  • Industries

    Biotech, Deep Tech

  • Locations

    London

  • Employees

    11 to 50

  • Investors

    Pioneer Group, Mercia Asset Management, Midlands Engine Investment Fund

  • Contact

    •••••@immuone.com
    Unlock contact info

Shorla Pharma
Shorla Pharma shorlapharma.com
62

Oncology treatment plalform.

  • Latest Funding

    $35 Million · Series B

  • Industries

    Biotech

  • Locations

    Cork

  • Employees

    1 to 10

  • Investors

    Kurma Partners, Enterprise Ireland, Seroba Life Sciences

  • Contact

    •••••@shorlapharma.com
    Unlock contact info

Better Dairy
Better Dairy betterdairy.co.uk
59

Building the future of food, starting with dairy.

  • Latest Funding

    $22 Million

  • Industries

    Agritech, Foodtech, Biotech, Manufacturing

  • Locations

    London

  • Employees

    1 to 10

  • Business Model

    B2B, B2C

  • Investors

    Entrepreneur First, CPT Capital, Redalpine, Vorwerk Ventures

  • Contact

    •••••@betterdairy.co.uk
    Unlock contact info

Daye
Daye yourdaye.com
59

Daye is a gynecological health company that creates products and services for vaginal treatment.

  • Latest Funding

    $12 Million · Series A

  • Industries

    Health Tech, Biotech, Manufacturing, Ecommerce, Cannabis

  • Locations

    London

  • Employees

    11 to 50

  • Business Model

    B2C

  • Investors

    Index Ventures, Kindred Capital, Khosla Ventures, Hambro Perks Ltd.

  • Contact

    •••••@yourdaye.com
    Unlock contact info

Hoxton Farms
Hoxton Farms hoxtonfarms.com
59

Based in London, UK, Hoxton Farms is growing cultivated fat as an ingredient for the meat alternatives industry.

  • Latest Funding

    $22 Million · Series A

  • Industries

    Foodtech, Biotech, Manufacturing

  • Locations

    London

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    BACKED VC, CPT Capital

  • Contact

    •••••@hoxtonfarms.com
    Unlock contact info

Lifebit
Lifebit lifebit.ai
59

Biomedical CloudOS data platform.

  • Latest Funding

    $60 Million · Series B

  • Industries

    Health Tech, Biotech, Data and Analytics, Business Intelligence

  • Locations

    London

  • Employees

    51 to 100

  • Business Model

    B2B, SAAS

  • Investors

    Eurazeo, Connect Ventures, Techstars, Tiny VC

  • Contact

    •••••@lifebit.ai
    Unlock contact info

Myricx Pharma
Myricx Pharma myricxpharma.com
59

Myricx Pharma is a drug discovery company focused on developing small molecule inhibitors.

  • Latest Funding

    $6 Million · Seed

  • Industries

    Health Tech, Biotech, Deep Tech, Pharma

  • Locations

    London

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Sofinnova Partners

  • Contact

    •••••@myricxpharma.com
    Unlock contact info

Opencell
Opencell opencell.bio
59

OpenCell builds biotech labs in shipping containers with the aim of making biotechnology accessible and affordable.

  • Latest Funding

    $8.2 Million

  • Industries

    Fintech, Biotech, Proptech & Real Estate, Manufacturing

  • Locations

    London

  • Employees

    1 to 10

  • Business Model

    B2B, SAAS

  • Investors

    Seventure Partners

  • Contact

    •••••@opencell.bio
    Unlock contact info

Pathfinder Medical
Pathfinder Medical pathfindermed.com
59

Pathfinder is developing a novel catheter based system that provides a better way for patients to receive haemodialysis for kidney failure.

  • Latest Funding

    $12 Million · Series A

  • Industries

    Health Tech, Biotech, Manufacturing

  • Locations

    London

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Business Growth Fund, Parkwalk Advisors, Deepbridge Capital

  • Contact

    •••••@pathfindermed.com
    Unlock contact info

Peptone
Peptone peptone.io
59

We are a translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered proteins.

  • Latest Funding

    $40 Million · Series A

  • Industries

    Health Tech, Biotech, Pharma, Manufacturing

  • Locations

    London

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Hoxton Ventures, Bessemer Venture Partners

  • Contact

    •••••@peptone.io
    Unlock contact info

Sixfold Bioscience
Sixfold Bioscience sixfold.bio
59

Sixfold Bioscience develops and researches on biotechnology advances for RNA therapies.

  • Latest Funding

    $10 Million

  • Industries

    Health Tech, Biotech, Robotics, Manufacturing, Business Intelligence

  • Locations

    London

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Y Combinator, Pi Campus

  • Contact

    •••••@sixfold.bio
    Unlock contact info

Bea Fertility
Bea Fertility beafertility.com
59

At-home fertility treatment.

  • Latest Funding

    $3.2 Million · Seed

  • Industries

    Health Tech, Biotech

  • Locations

    London

  • Employees

    1 to 10

  • Business Model

    B2C

  • Investors

    Octopus Ventures, Calm/Storm Ventures, QVentures

  • Contact

    •••••@beafertility.com
    Unlock contact info

Nature Metrics
Nature Metrics naturemetrics.co.uk
59

Developer of cutting-edge DNA techniques to monitor biodiversity.

  • Latest Funding

    $13 Million · Series A

  • Industries

    Biotech

  • Locations

    London

  • Employees

    11 to 50

  • Investors

    SYSTEMIQ, BNP Paribas, Green Angel Ventures, Triple Point Ventures

  • Contact

    •••••@naturemetrics.co.uk
    Unlock contact info

F2G
F2G f2g.com
56

F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases.

  • Latest Funding

    $70 Million

  • Industries

    Health Tech, Biotech, Pharma, Genetics

  • Locations

    Manchester

  • Employees

    251 to 500

  • Business Model

    B2B

  • Investors

    Sofinnova Partners, Novo A/S, Forbion Capital Partners

  • Contact

    •••••@f2g.com
    Unlock contact info

Healx
Healx healx.io
56

Healx is an AI-powered, patient-inspired technology company, pioneering the next generation of drug discovery for rare diseases.

  • Latest Funding

    $56 Million · Series B

  • Industries

    Health Tech, AI, Biotech, Pharma, Data and Analytics, Business Intelligence

  • Locations

    Cambridge

  • Employees

    51 to 100

  • Business Model

    B2B, SAAS

  • Investors

    Balderton Capital, Atomico, btov Partners, Amadeus Capital

  • Contact

    •••••@healx.io
    Unlock contact info

Microbiotica
Microbiotica microbiotica.com
56

Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers.

  • Latest Funding

    $67 Million

  • Industries

    Health Tech, Biotech, Deep Tech, Manufacturing

  • Locations

    Cambridge

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Seventure Partners, Cambridge Innovation Capital

  • Contact

    •••••@microbiotica.com
    Unlock contact info

MiroBio
MiroBio mirobio.com
56

MiroBio is Harnessing the natural control mechanisms of the immune system.

  • Latest Funding

    $97 Million · Series B

  • Industries

    Health Tech, Biotech, Deep Tech

  • Locations

    Oxford

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Medicxi, Oxford Science Enterprises

  • Contact

    •••••@mirobio.com
    Unlock contact info

Mogrify
Mogrify mogrify.co.uk
56

Mogrify® will transform the development of ex vivo cell therapies and pioneer a new class of in vivo reprogramming therapies.

  • Latest Funding

    $10 Million · Series A

  • Industries

    Health Tech, Biotech, Deep Tech

  • Locations

    Cambridge

  • Employees

    101 to 250

  • Business Model

    B2B

  • Investors

    Astellas Venture Management, Ahren Innovation Capital, Parkwalk Advisors

  • Contact

    •••••@mogrify.co.uk
    Unlock contact info

ONI
ONI oni.bio
56

ONI is a pioneer of super-resolution microscopy, making this advanced technology accessible to new generations of researchers.

  • Latest Funding

    $75 Million · Series B

  • Industries

    Health Tech, Biotech, Deep Tech, Robotics, Manufacturing, Developer Tools

  • Locations

    Oxford

  • Employees

    51 to 100

  • Business Model

    B2B

  • Investors

    Axon Ventures, Oxford Science Enterprises

  • Contact

    •••••@oni.bio
    Unlock contact info

Osler Diagnostics
Osler Diagnostics oslerdiagnostics.com
56

Lab-quality diagnostics for anyone, anywhere, at any time.

  • Latest Funding

    $85 Million · Series C

  • Industries

    Health Tech, Biotech, Deep Tech, Pharma

  • Locations

    Oxford

  • Employees

    51 to 100

  • Business Model

    B2B

  • Investors

    Oxford Science Enterprises

  • Contact

    •••••@oslerdiagnostics.com
    Unlock contact info

Oxford Nanopore Technologies
Oxford Nanopore Technologies nanoporetech.com
56

Oxford Nanopore Technologies develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins.

  • Latest Funding

    $280 Million

  • Industries

    Health Tech, Biotech, Pharma, Robotics, Manufacturing, Genetics

  • Locations

    Oxford

  • Employees

    251 to 500

  • Business Model

    B2B

  • Investors

    Wellington Management

  • Contact

    •••••@nanoporetech.com
    Unlock contact info

Harness Therapeutics
Harness Therapeutics harnesstx.com
56

Physiological upregulation therapy to treat neurodegenerative diseases.

  • Latest Funding

    $5.1 Million · Seed

  • Industries

    Health Tech, Biotech

  • Locations

    Cambridge

  • Employees

    11 to 50

  • Investors

    SV Health Investors

  • Contact

    •••••@harnesstx.com
    Unlock contact info

Epoch Biodesign
Epoch Biodesign epochbiodesign.com
54

Epoch develops natural solutions to unnatural problems. First up: enzymes that transform plastics into circular chemicals.

  • Latest Funding

    $11 Million · Seed

  • Industries

    Biotech, Manufacturing

  • Locations

    London

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Lowercarbon Capital, BoxGroup, Amadeus Capital, Ascension Ventures, Plug and Play Spain

  • Contact

    •••••@epochbiodesign.com
    Unlock contact info

FabricNano
FabricNano fabricnano.com
54

FabricNano is a cell-free biomanufacturing company that develops biocatalysts to unlock the future of biochemistry.

  • Latest Funding

    $13 Million · Series A

  • Industries

    Biotech, Energy & Nuclear, Robotics, Manufacturing

  • Locations

    London

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Hoxton Ventures, BACKED VC, Atomico, Entrepreneur First

  • Contact

    •••••@fabricnano.com
    Unlock contact info

Pheon Therapeutics
Pheon Therapeutics pheontx.com
54

Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers.

  • Latest Funding

    $68 Million · Series A

  • Industries

    Health Tech, Biotech, Deep Tech, Pharma

  • Locations

    London

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Forbion Capital Partners

  • Contact

    •••••@pheontx.com
    Unlock contact info

BioCorteX
BioCorteX biocortex.co.uk
54

Computer simulation to understand drug-bacteria interactions.

  • Latest Funding

    $5 Million · Seed

  • Industries

    Biotech

  • Locations

    London

  • Employees

    1 to 10

  • Investors

    Hoxton Ventures, Sofinnova Partners

  • Contact

    •••••@biocortex.co.uk
    Unlock contact info

Quaisr
Quaisr quaisr.io
54

Digital-twin simulator.

  • Latest Funding

    $3.1 Million · Pre Seed

  • Industries

    Biotech, Supply Chain & Logistics

  • Locations

    London

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Crane Venture Partners

  • Contact

    •••••@quaisr.io
    Unlock contact info

Actimed Therapeutics
Actimed Therapeutics actimedtherapeutics.com
54

Developer of innovative treatment for muscle wasting disorders.

  • Latest Funding

    $6.1 Million · Series A

  • Industries

    Biotech, Pharma

  • Locations

    London

  • Employees

    1 to 10

  • Investors

    Mankind Pharma

  • Contact

    •••••@actimedtherapeutics.com
    Unlock contact info

Bastion Therapeutics
Bastion Therapeutics bastion-tx.com
54

Developer of novel Treg therapies to treat inflammatory disorders.

  • Latest Funding

    $840 Thousand · Pre Seed

  • Industries

    Health Tech, Biotech

  • Locations

    London

  • Employees

    1 to10

  • Business Model

    B2C

  • Investors

    Deep Science Ventures, Wren Capital

  • Contact

    •••••@bastion-tx.com
    Unlock contact info

Ascend Gene & Cell Therapies
Ascend Gene & Cell Therapies ascend-gctx.com
53

Gene and cell therapy manufacturing.

  • Latest Funding

    $66 Million · Series A

  • Industries

    Biotech

  • Locations

    London

  • Employees

    11 to 50

  • Contact

    •••••@ascend-gctx.com
    Unlock contact info

bit.bio
bit.bio bit.bio
51

Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell.

  • Latest Funding

    $100 Million · Series B

  • Industries

    Health Tech, Biotech, Deep Tech, Business Intelligence

  • Locations

    Cambridge

  • Employees

    101 to 250

  • Business Model

    B2B

  • Investors

    BlueYard Capital, Metaplanet Holdings

  • Contact

    •••••@bit.bio
    Unlock contact info

Eagle Genomics
Eagle Genomics eaglegenomics.com
51

Eagle Genomics is a enterprise software solutions company to enable the management, orchestration and exploitation of life sciences data.

  • Latest Funding

    $3.6 Million · Seed

  • Industries

    Health Tech, Biotech

  • Locations

    Cambridge

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Granpool Innovative Investments, ETF Partners

  • Contact

    •••••@eaglegenomics.com
    Unlock contact info

Nuclera
Nuclera nuclera.com
51

Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis.

  • Latest Funding

    $16 Million · Series B

  • Industries

    Biotech, Deep Tech, Manufacturing

  • Locations

    Cambridge

  • Employees

    11 to 50

  • Business Model

    B2B

  • Investors

    Future Planet Capital, Amadeus Capital, Verve Ventures

  • Contact

    •••••@nuclera.com
    Unlock contact info

Grey Wolf Therapeutics
Grey Wolf Therapeutics greywolftherapeutics.com
51

Small molecules to increase tumor detection by the immune system.

  • Latest Funding

    $49 Million · Series B

  • Industries

    Biotech

  • Locations

    Oxford

  • Employees

    1 to 10

  • Investors

    Earlybird Venture Capital

  • Contact

    •••••@greywolftherapeutics.com
    Unlock contact info

Mosaic Therapeutics
Mosaic Therapeutics mosaic-tx.com
51

Anti-cancer drug developer.

  • Latest Funding

    $28 Million · Series A

  • Industries

    Biotech

  • Locations

    Cambridge

  • Employees

    101 to 250

  • Investors

    Syncona Partners LLP, Cambridge Innovation Capital

  • Contact

    •••••@mosaic-tx.com
    Unlock contact info

evonetix
evonetix evonetix.com
51

DNA synthesis technology researcher.

  • Latest Funding

    $24 Million · Series B

  • Industries

    Biotech

  • Locations

    Cambridge

  • Employees

    11 to 50

  • Investors

    Foresite Capital

  • Contact

    •••••@evonetix.com
    Unlock contact info

Broken String Biosciences
Broken String Biosciences brokenstringbio.com
51

Genomics company building safer cell and gene therapies.

  • Latest Funding

    $15 Million · Series A

  • Industries

    Health Tech, Biotech

  • Locations

    Cambridge

  • Employees

    1 to 10

  • Investors

    Tencent, Illumina Ventures

  • Contact

    •••••@brokenstringbio.com
    Unlock contact info

Pencil Biosciences
Pencil Biosciences pencilbiosciences.com
51

Advanced gene editing paltform for rare diseases.

  • Latest Funding

    $6.8 Million · Seed

  • Industries

    Health Tech, Biotech

  • Locations

    Manchester

  • Employees

    1 to 10

  • Investors

    Octopus Ventures, Northern Gritstone

  • Contact

    •••••@pencilbiosciences.com
    Unlock contact info

Arborea
Arborea arborea.io
50

Arborea is industrialising photosynthesis to expand the world’s food supply

  • Latest Funding

    $4.1 Million · Seed

  • Industries

    Climate Tech & Green Tech, Foodtech, Biotech, Manufacturing

  • Locations

    London

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Business Growth Fund

  • Contact

    •••••@arborea.io
    Unlock contact info

Baseimmune
Baseimmune baseimmune.co.uk
50

Baseimmune is a biotech startup founded to create the next generation of vaccines.

  • Latest Funding

    $4.8 Million · Seed

  • Industries

    Health Tech, Biotech, Deep Tech, Pharma, Manufacturing

  • Locations

    London

  • Employees

    1 to 10

  • Business Model

    B2B

  • Investors

    Hoxton Ventures, Cherry Ventures, Maki.vc, Creator Fund

  • Contact

    •••••@baseimmune.co.uk
    Unlock contact info

DnaNudge
DnaNudge dnanudge.com
50

dnaNUDGE aims to nudge people towards a better lifestyle based on their DNA.

  • Latest Funding

    $60 Million · Series A

  • Industries

    Health Tech, Biotech, Manufacturing

  • Locations

    London

  • Employees

    11 to 50

  • Business Model

    B2B

  • Contact

    •••••@dnanudge.com
    Unlock contact info

Foodsteps
Foodsteps foodsteps.earth
50

Foodsteps is a london-based startup that has developed a platform to help the food sector reduce its carbon footprint.

  • Latest Funding

    $4.1 Million

  • Industries

    Climate Tech & Green Tech, Health Tech, Agritech, Foodtech, Biotech, Deep Tech, Energy & Nuclear, Business Intelligence

  • Locations

    London

  • Employees

    11 to 50

  • Business Model

    B2B, SAAS

  • Investors

    Octopus Ventures, Ascension Ventures, Metaplanet Holdings

  • Contact

    •••••@foodsteps.earth
    Unlock contact info

Gardin
Gardin gardin.co.uk
50

Gardin develops optical phenotyping technology and analytics to optimise food production.

  • Latest Funding

    $11 Million · Seed

  • Industries

    Agritech, Foodtech, Biotech, Data and Analytics

  • Locations

    London

  • Employees

    11 to 50

  • Business Model

    B2B, SAAS

  • Investors

    Molten Ventures, Seedcamp, MMC Ventures

  • Contact

    •••••@gardin.co.uk
    Unlock contact info